Hosted on MSN10m
Moderna Q4 Earnings and Revenues Beat, COVID Vaccine Sales Decline
Moderna MRNA incurred a loss of $2.50 per share in the fourth quarter of 2024, narrower than the Zacks Consensus Estimate of ...
FDA Greenlights U.S. Clinical Trial for New Nasal COVID-19 Vaccine
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
Medical Design and Outsourcing1h
Nasal vaccine devices: Design and regulatory need-to-knows
Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.
wwmt2d
Thomas Massie calls on FDA to 'immediately' reverse course on COVID vaccines
Ky., on Wednesday called on the Food and Drug Administration to reverse its approval of some COVID-19 vaccines.
Why the COVID Deniers Won
By disparaging public-health methods and discrediting vaccines, the COVID‑19 minimizers cost hundreds of thousands of people ...
No, Moderna Did Not Create Its COVID Vaccine Two Years Before the Pandemic
An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...
House committee takes testimony on bill that would ban certain vaccines in Montana
Legislation that would ban mRNA vaccinations statewide — including the Covid-19 vaccine — drew equal parts support and ...
Senate to vote on vaccine skeptic Robert F. Kennedy Jr.'s bid to become nation's health secretary
WASHINGTON -- The Senate is expected to vote Thursday on the confirmation of Robert F. Kennedy Jr ., a prominent lawyer and ...
In Idaho, a preview of RFK Jr.’s vaccine-skeptical America
This Idaho health district banned public clinics from distributing the coronavirus vaccine as widespread fear during the ...
cidrap.umn3d
Financial incentives did not increase COVID vaccine uptake, study finds
Among adults in Ravensburg, Germany, financial incentives for COVID-19 vaccination did not result in significant changes to vaccine uptake and may have inadvertently lowered community vaccination ...
NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...
New nasal vaccine for COVID-19 set to begin clinical trial in the U.S.
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...